Opendata, web and dolomites

Miiskin SIGNED

ML-powered app and platform to identify skin changes over time

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Miiskin project word cloud

Explore the words cloud of the Miiskin project. It provides you a very rough idea of what is the project "Miiskin" about.

body    monitoring    unlocking    tool    manually    time    consuming    diagnosed    melanocytes    melapp    survival    node    market    automatic    helping    mostly    rate    400    minimum    successful    healthy    expansion    nevertheless    app    commercial    competitive    lymphatic    previously    25    mortality    treating    australia    poles    africa    south    clinical    unprecise    close    highest    endorsement    acquired    mole    innovation    cancer    treatment    intelligence       ambition    certification    worldwide    bearing    artificial    malignant    made    250    mm    reduce    risk    miiskin    tumour    denmark    232    position    spotting    detection    diagnose    patient    identification    apps    countries       teledermatology    metastases    lacking    seal    deaths    skin    skinvision    created    dermatologically    photo    innovative    doctor    sign    originates    monitor    concentrated    globally    moles    melanoma    caused    quality    people    responsible    supporting    thanks    efficient       2030    healthcare    98    norway   

Project "Miiskin" data sheet

The following table provides information about the project.

Coordinator
MIISKIN APS 

Organization address
address: FRUEBJERGVEJ 3
city: København O
postcode: 2100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MIISKIN APS DK (København O) coordinator 50˙000.00

Map

 Project objective

Malignant Melanoma (MM) is a tumour which originates mostly in the skin melanocytes and is responsible for most deaths caused by skin cancer, due to the high risk of lymphatic metastases and expansion to other areas of the body. Globally, 232,000 people are diagnosed with MM every year, 90,000 of those concentrated in Europe. While early detection of melanoma has a 98% survival rate, late detection has only a 10-25% survival rate, with a mortality rate going from 3% in countries like Norway or Denmark to 6-7% in other areas close to the poles like South Africa or Australia. Treating MM cost to the healthcare system a minimum of €10,000 to €250,000€ per patient. People at high risk of developing MM or healthy people who has previously been diagnose with MM skin cancer have to regularly monitor their skin and moles for changes. Any skin/mole change can be an early sign of skin cancer and early detection of melanoma is crucial for successful treatment. Nevertheless, the process of spotting manually new changes in the skin can be highly time consuming and unprecise, as it is done manually or using commercial apps (MelApp, SkinVision) lacking clinical certification. We have created, Miiskin app as a supporting tool to help users to monitor skin changes over time with an innovative technology application based in artificial intelligence. Thanks to our innovation, we made the monitoring process more efficient and reliable, helping in the identification of new moles through automatic photo comparison. Moreover, Miiskin will be used as patient-doctor node fully unlocking the potential of teledermatology. Thanks to that we are the unique app worldwide bearing the dermatologically endorsement quality seal. We have already acquired a strong and highly competitive market position as well as the highest rate among Skin Cancer apps, involving more than 400,000 users worldwide. With this ambition we aim to reduce skin cancer mortality to 1% by 2030.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIISKIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIISKIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ARON (2020)

Assay-Ready Organ Network

Read More  

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

VACTEC (2019)

VACTEC_Responsive corrosion inhibiting Vacuum Technology-based fire protection system

Read More